Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04653324 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Registry for the Food Allergy Community

Study acronym: FPR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv7
  2. Notable Primary and study completion dates: Aug 2025 to Aug 2027v6
  3. Notable Primary and study completion dates: Aug 2023 to Aug 2025v5
  4. Notable Enrollment target: 12000 to 23000v4 Show 4 more changesShow less
    • Study sites: 20 to 1
    • Publications revised (5)
    • Study title revised
    • Eligibility criteria shortened, about 3 words
  5. Minor Publications: 4 to 5v3
  6. Minor Publications: 3 to 4v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials. The FARE Patient Registry intends to make and support scientific discoveries by enabling the food allergy community to participate directly in research.
Trial Details
NCT Number NCT04653324
Lead Sponsor Food Allergy Research & Education
Conditions
(from sponsor)
Food Hypersensitivity, Anaphylaxis, Eosinophilic Esophagitis, Food Sensitivity, Food Intolerance, Food Allergy in Infants
Related terms Anaphylaxis, Eosinophilic Esophagitis, Food Hypersensitivity, Food Intolerance
Enrollment 23,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov